The global acne therapeutics market is expected to register a CAGR of approximately 3.5% during the forecast period (2018 - 2023). Acne is considered to be among the topmost prevalent diseases in the world. The rising awareness among the teenagers and the rising healthcare expenditure in developed as well as parts of emerging markets is expected to drive the acne therapeutics market.
The diet and the nutrients intake determine the overall health of an individual. Several studies suggest that lack of some nutrition or excess of one or other food could cause the acne. The food habits with high glycemic index, such as sugar, white bread, and white rice, leads to higher serum glucose levels and elevated levels of insulin. This, in turn, increases sebum production, increases adrenal androgen synthesis, and androgen bioavailability, all of them play a role in the development of acne. This is predominantly being observed in the age group of 15-25 years of population, globally, which is one of the primary factors for the growth of acne therapeutics market.
Other factors responsible for the growth of this market are rising global prevalence of acne due to lifestyle changes, the rise in the disposable income of consumers which encourages them to purchase high-quality skin care products, along with current and upcoming treatments for acne.
One of the major factors considered to be the obstacle for the acne therapeutics market is safety and associated side-effects with these products. Although most products are considered safe, in past FDA has released causes for concerns regarding acne products containing the active ingredients benzoyl peroxide or salicylic acid which could cause rare but serious life-threatening allergic reactions for long durations. This includes others symptoms such as shortness of breath, wheezing, low blood pressure, and swelling of eyes, face, and lips. Therefore, safety issues regarding these products are expected to impede the growth of this market.
The entry of generics in this market is expected to hamper the growth of this market.
North America is expected to dominate the market owing to a rising awareness and the growing population of teenagers as well as the growing healthcare expenditure in the region. It is one of the most common disorders in the United States and affects a large section of teenagers and young adults including primarily the female patient’s population. Factors such as lifestyle changes, awareness programs regarding acne, and easy availability of acne treatments drive this market in this region. Apart from this, Asia-Pacific is expected to grow at a higher rate compared to other regions, due to a largely diversified patient pool including a major section of the population in the young adults age-group as well as the rising healthcare infrastructure.
Major players: Allergan PLC, Bayer AG, Cipher Pharmaceuticals Inc., Galderma SA, GlaxoSmithKline PLC, Johnson & Johnson, Roche Holding AG, Stiefel Laboratories, Inc., Teva Pharmaceutical Industries, and Valeant Pharmaceuticals International Inc., among others.
Looking to Customize Report?